 Connection
Andrew Bradford to Retinoblastoma Protein
This is a "connection" page, showing publications Andrew Bradford has written about Retinoblastoma Protein.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.362 |
|
|
|
-
Nakajima R, Zhou Y, Shirasawa M, Fikriyanti M, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB. Genes (Basel). 2025 Aug 01; 16(8).
Score: 0.218
-
Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Kitagawa M, San TY, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Murine Embryonic Stem Cells Possess Distinct E2F Activity That Activates Tumor Suppressor Promoter Elements. Genes Cells. 2026 May; 31(3):e70121.
Score: 0.057
-
Zhou Y, Nakajima R, Shirasawa M, Fikriyanti M, Watanabe A, Yang C, Iwanaga R, Bradford AP, Kurayoshi K, Araki K, Ohtani K. Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells. Cells. 2026 Jan 05; 15(1).
Score: 0.056
-
Kurayoshi K, Okuno J, Ozono E, Iwanaga R, Bradford AP, Kugawa K, Araki K, Ohtani K. The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity. Biochem Biophys Res Commun. 2017 Jan 22; 482(4):784-790.
Score: 0.030
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|